Literature DB >> 12505282

The natural history of hepatocellular carcinoma.

Raffaella Romeo1, Massimo Colombo.   

Abstract

Hepatocellular carcinoma (HCC) is a multistage disease whose occurrence is linked to environmental, dietary and life-style factors. Risk factors for HCC have been grouped into two clusters, physiologic and pathologic factors. Much evidence indicates that these risk factors may interact with each other either as a group or as a single factor to modulate development of liver cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12505282     DOI: 10.1016/s0300-483x(02)00252-4

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  7 in total

1.  The effects of a novel MEK inhibitor PD184161 on MEK-ERK signaling and growth in human liver cancer.

Authors:  Patrick J Klein; C Max Schmidt; Chad A Wiesenauer; Jennifer N Choi; Earl A Gage; Michele T Yip-Schneider; Eric A Wiebke; Yufang Wang; Charles Omer; Judith S Sebolt-Leopold
Journal:  Neoplasia       Date:  2006-01       Impact factor: 5.715

2.  Contribution of gut bacteria to liver pathobiology.

Authors:  Gakuhei Son; Michael Kremer; Ian N Hines
Journal:  Gastroenterol Res Pract       Date:  2010-07-28       Impact factor: 2.260

3.  Liver angiogenesis as a risk factor for hepatocellular carcinoma development in hepatitis C virus cirrhotic patients.

Authors:  Roberto Mazzanti; Luca Messerini; Camilla E Comin; Lorenzo Fedeli; Nathalie Ganne-Carrie; Michel Beaugrand
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

4.  Effect of Qi-protecting powder (Huqi San) on expression of c-jun, c-fos and c-myc in diethylnitrosamine-mediated hepatocarcinogenesis.

Authors:  Xia Li; Zheng-Ming Shi; Ping Feng; Zhao-Yang Wen; Xue-Jiang Wang
Journal:  World J Gastroenterol       Date:  2007-08-21       Impact factor: 5.742

5.  TP53 and MDM2 gene polymorphisms and risk of hepatocellular carcinoma among Italian patients.

Authors:  Valeria Di Vuolo; Luigi Buonaguro; Francesco Izzo; Simona Losito; Gerardo Botti; Franco M Buonaguro; Maria Lina Tornesello
Journal:  Infect Agent Cancer       Date:  2011-08-15       Impact factor: 2.965

6.  Gene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinoma.

Authors:  Valeria De Giorgi; Alessandro Monaco; Andrea Worchech; Marialina Tornesello; Francesco Izzo; Luigi Buonaguro; Francesco M Marincola; Ena Wang; Franco M Buonaguro
Journal:  J Transl Med       Date:  2009-10-12       Impact factor: 5.531

7.  Molecular signatures associated with HCV-induced hepatocellular carcinoma and liver metastasis.

Authors:  Valeria De Giorgi; Luigi Buonaguro; Andrea Worschech; Maria Lina Tornesello; Francesco Izzo; Francesco M Marincola; Ena Wang; Franco M Buonaguro
Journal:  PLoS One       Date:  2013-02-18       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.